Medscape | Roche Cancer Drug Gets Agency Approval - WSJ.com Wall Street Journal The European Medicines Agency Friday recommended Roche Holding AG's Perjeta breast cancer treatment for approval, a drug the Swiss drug maker hopes will help defend a lucrative franchise as other drugs lose patent protection. The agency's Committee ... |
Our Goal: to provide an easy, affordable and informative means for our customers to purchase home medical equipment and supplies from the comfort of their homes and medical offices.
Friday, December 14, 2012
Roche Cancer Drug Gets Agency Approval - WSJ.com - Wall Street Journal
Roche Cancer Drug Gets Agency Approval - WSJ.com - Wall Street Journal:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment